• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Feb 2;15(1):1008.
doi: 10.1038/s41467-024-44973-1. Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population

Jia Wei[SUP] 1 2 [/SUP], Nicole Stoesser[SUP] 3 4 5 6 [/SUP], Philippa C Matthews[SUP] 3 7 8 [/SUP], Tarnjit Khera[SUP] 9 [/SUP], Owen Gethings[SUP] 9 [/SUP], Ian Diamond[SUP] 9 [/SUP], Ruth Studley[SUP] 9 [/SUP], Nick Taylor[SUP] 9 [/SUP], Tim E A Peto[SUP] 3 4 5 6 [/SUP], A Sarah Walker[SUP] #[/SUP][SUP] 3 10 5 11 [/SUP], Koen B Pouwels[SUP] #[/SUP][SUP] 5 12 [/SUP], David W Eyre[SUP] #[/SUP][SUP] 10 4 5 6 [/SUP]; COVID-19 Infection Survey team



Collaborators, Affiliations
Free PMC article Abstract

SARS-CoV-2 reinfections increased substantially after Omicron variants emerged. Large-scale community-based comparisons across multiple Omicron waves of reinfection characteristics, risk factors, and protection afforded by previous infection and vaccination, are limited. Here we studied ~45,000 reinfections from the UK's national COVID-19 Infection Survey and quantified the risk of reinfection in multiple waves, including those driven by BA.1, BA.2, BA.4/5, and BQ.1/CH.1.1/XBB.1.5 variants. Reinfections were associated with lower viral load and lower percentages of self-reporting symptoms compared with first infections. Across multiple Omicron waves, estimated protection against reinfection was significantly higher in those previously infected with more recent than earlier variants, even at the same time from previous infection. Estimated protection against Omicron reinfections decreased over time from the most recent infection if this was the previous or penultimate variant (generally within the preceding year). Those 14-180 days after receiving their most recent vaccination had a lower risk of reinfection than those >180 days from their most recent vaccination. Reinfection risk was independently higher in those aged 30-45 years, and with either low or high viral load in their most recent previous infection. Overall, the risk of Omicron reinfection is high, but with lower severity than first infections; both viral evolution and waning immunity are independently associated with reinfection.


 
Back
Top Bottom